Showing results (231-240 of 367) with videos related to

Sort By:
Pageof 37
International Journal of Cancer|April 28, 2015
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cellsElisa Göckeritz, Susan Kerwien, Michael Baumann, et al.
Mabs|November 5, 2020
Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivoCornelia Fischer, Michael W Munks, Ann B Hill, et al.
Blood Advances|January 22, 2026
Molecular Features of Response and Resistance to Glofitamab, a T-Cell Engager for treatment of Large B-Cell LymphomaStephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseasesKonrad L Streetz, Frank Tacke, Ludger Leifeld, et al.
Lung Cancer (Amsterdam, Netherlands)|March 11, 2021
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutationPablo Moreno-Ruiz, Sara Corvigno, Nienke C Te Grootenhuis, et al.
Cells|May 13, 2026
Distinct Extracellular Matrix Protein Signatures of Cortical and Cancellous Bone Allografts Following Processing for Clinical UseAdrian Lendvai, Hans Peter Weitzenböck, Christian Klein, et al.
Mabs|June 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-BrainshuttleTM variantsTatjana Sela, Tamara Wirth, Annika Sommer, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in miceTorsten Wuestefeld, Christian Klein, Konrad L Streetz, et al.
Rheumatology (Oxford, England)|November 17, 2021
Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?Venkat R Reddy, Ruth J Pepper, Kavina Shah, et al.
Mabs|February 12, 2016
Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2Werner Scheuer, Markus Thomas, Petra Hanke, et al.
Pageof 37